Two Sigma Securities’s Pacific Biosciences PACB Stock Holding History

Two Sigma Securities’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-32,017	Closed	-$39.7K	–	1855
2025 Q2	$39.7K	Sell	32,017 -1,021	-3%	-$1.18K	﹤0.01%	1130
2025 Q1	$39K	Buy	+33,038	New	+$50.7K	0.01%	1022
2023 Q2	–	Sell	-11,995	Closed	-$139K	–	3194
2023 Q1	$139K	Buy	+11,995	New	+$119K	﹤0.01%	2152
2022 Q4	–	Sell	-13,908	Closed	-$81K	–	3083
2022 Q3	$81K	Sell	13,908 -8,859	-39%	-$50.8K	﹤0.01%	2126
2022 Q2	$101K	Buy	+22,767	New	+$138K	﹤0.01%	1750
2019 Q3	–	Sell	-16,622	Closed	-$101K	–	2342
2019 Q2	$101K	Buy	+16,622	New	+$117K	﹤0.01%	1848

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Madrone Advisors Menlo Park, California $1.39B AUM 10.34% 1-Year Est. Return

Two Sigma Securities's PACB Position: Q3 2025 in Review

Two Sigma Securities sold out of Pacific Biosciences (PACB) in Q3 2025, closing a stake of 32,017 shares — an estimated $39.7K sold.

Two Sigma Securities first reported a position in PACB in Q2 2019 and held it in 6 quarters. The position peaked at $139K in Q1 2023. 208 funds tracked by Wall St. Rank hold PACB as of Q3 2025.

Two Sigma Securities reported no remaining Pacific Biosciences position as of Q3 2025 after selling out during the quarter.
Two Sigma Securities sold 32,017 Pacific Biosciences shares in Q3 2025, an estimated $39.7K.
Two Sigma Securities first reported a position in Pacific Biosciences in Q2 2019 and held it in 6 quarters.
Two Sigma Securities's Pacific Biosciences position peaked at $139K in Q1 2023.
208 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.